SP8
gene geneOn this page
Summary
SP8 (Sp8 transcription factor, HGNC:19196) is a protein-coding gene on chromosome 7p21.1, encoding Transcription factor Sp8 (Q8IXZ3). Transcription factor which plays a key role in limb development.
The protein encoded by this gene is an SP family transcription factor that in mouse has been shown to be essential for proper limb development. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 221833 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_182700
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19196 |
| Approved symbol | SP8 |
| Name | Sp8 transcription factor |
| Location | 7p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000164651 |
| Ensembl biotype | protein_coding |
| OMIM | 608306 |
| Entrez | 221833 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000361443, ENST00000418710
RefSeq mRNA: 2 — MANE Select: NM_182700
NM_182700, NM_198956
CCDS: CCDS43555, CCDS5372
Canonical transcript exons
ENST00000418710 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003471433 | 20782279 | 20785795 |
| ENSE00003488541 | 20786778 | 20786886 |
Expression profiles
Bgee: expression breadth broad, 76 present calls, max score 98.38.
FANTOM5 (CAGE): breadth broad, TPM avg 3.1081 / max 378.2798, expressed in 247 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83022 | 1.2405 | 123 |
| 83025 | 0.7555 | 205 |
| 83024 | 0.4021 | 128 |
| 83023 | 0.2367 | 57 |
| 83020 | 0.1171 | 69 |
| 83016 | 0.0812 | 45 |
| 83018 | 0.0775 | 37 |
| 83017 | 0.0700 | 32 |
| 83021 | 0.0697 | 34 |
| 83019 | 0.0446 | 25 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 98.38 | gold quality |
| sural nerve | UBERON:0015488 | 92.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.71 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 84.38 | silver quality |
| ventricular zone | UBERON:0003053 | 83.70 | gold quality |
| upper arm skin | UBERON:0004263 | 82.06 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.36 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 80.86 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 78.92 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.32 | gold quality |
| kidney epithelium | UBERON:0004819 | 77.81 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 74.49 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 74.20 | gold quality |
| tibialis anterior | UBERON:0001385 | 73.69 | silver quality |
| buccal mucosa cell | CL:0002336 | 73.22 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 68.71 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 68.46 | gold quality |
| prostate gland | UBERON:0002367 | 67.30 | gold quality |
| endothelial cell | CL:0000115 | 67.17 | gold quality |
| oocyte | CL:0000023 | 64.13 | gold quality |
| sperm | CL:0000019 | 62.99 | gold quality |
| deltoid | UBERON:0001476 | 62.81 | gold quality |
| ileal mucosa | UBERON:0000331 | 61.87 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 61.57 | gold quality |
| cortical plate | UBERON:0005343 | 60.34 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 60.34 | gold quality |
| skin of hip | UBERON:0001554 | 59.31 | silver quality |
| parotid gland | UBERON:0001831 | 59.28 | gold quality |
| myocardium | UBERON:0002349 | 58.54 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-93593 | yes | 126.72 |
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| FGF8 | Activation |
| PAX6 | Unknown |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0747.1 | SP8 | Three-zinc finger Kruppel-related |
| MA0747.2 | SP8 | Three-zinc finger Kruppel-related |
JASPAR matrix evidence (PMIDs): PMID:23019068
Upstream regulators (CollecTRI, top): EMX2
miRNA regulators (miRDB)
152 targeting SP8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
Literature-anchored findings (GeneRIF, showing 3)
- This study provided that SP8 are associated with Bipolar I in the Han Chinese population (PMID:20386566)
- Genetic variants on 3q21 and in the Sp8 transcription factor gene (SP8) as susceptibility loci for psychotic disorders. (PMID:23967141)
- Data suggest expression of transcription factor p8/SP8 is up-regulated in endoplasmic reticulum stress due to lipotoxicity; overexpression of SP8 up-regulates autophagy; autophagy due to lipotoxicity requires SP8; these reactions are mTOR-independent. (PMID:26733200)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sp8b | ENSDARG00000056666 |
| mus_musculus | Sp8 | ENSMUSG00000048562 |
| rattus_norvegicus | Sp8 | ENSRNOG00000068174 |
| drosophila_melanogaster | luna | FBGN0040765 |
Paralogs (22): KLF6 (ENSG00000067082), KLF8 (ENSG00000102349), KLF5 (ENSG00000102554), KLF1 (ENSG00000105610), KLF3 (ENSG00000109787), KLF7 (ENSG00000118263), KLF12 (ENSG00000118922), KLF9 (ENSG00000119138), KLF2 (ENSG00000127528), KLF16 (ENSG00000129911), KLF4 (ENSG00000136826), KLF10 (ENSG00000155090), KLF15 (ENSG00000163884), KLF13 (ENSG00000169926), SP7 (ENSG00000170374), KLF17 (ENSG00000171872), KLF11 (ENSG00000172059), SP6 (ENSG00000189120), SP5 (ENSG00000204335), SP9 (ENSG00000217236), KLF14 (ENSG00000266265), KLF18 (ENSG00000283039)
Protein
Protein identifiers
Transcription factor Sp8 — Q8IXZ3 (reviewed: Q8IXZ3)
Alternative names: Specificity protein 8
All UniProt accessions (1): Q8IXZ3
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor which plays a key role in limb development. Positively regulates FGF8 expression in the apical ectodermal ridge (AER) and contributes to limb outgrowth in embryos.
Subcellular location. Nucleus.
Domain organisation. The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.
Similarity. Belongs to the Sp1 C2H2-type zinc-finger protein family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXZ3-3 | 3 | yes |
| Q8IXZ3-1 | 1 | |
| Q8IXZ3-2 | 2 | |
| Q8IXZ3-4 | 4, Sp8L |
RefSeq proteins (2): NP_874359, NP_945194 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (18 total): compositionally biased region 5, region of interest 4, zinc finger region 3, splice variant 3, chain 1, sequence conflict 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXZ3-F1 | 48.24 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
TGACCTY_ERR1_Q2, LHX3_01, GOBP_DORSAL_VENTRAL_PATTERN_FORMATION, TCF4_Q5, GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION, GOBP_APPENDAGE_DEVELOPMENT, HNF4_01, MAF_Q6, HNF1_C, GFI1_01, LEF1_Q6, GOBP_EMBRYO_DEVELOPMENT, CTTTGTA_MIR524, RAAGNYNNCTTY_UNKNOWN, TAATTA_CHX10_01
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), dorsal/ventral pattern formation (GO:0009953), proximal/distal pattern formation (GO:0009954), embryonic limb morphogenesis (GO:0030326)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regionalization | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| limb morphogenesis | 1 |
| embryonic appendage morphogenesis | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
796 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SP8 | CALB2 | P22676 | 863 |
| SP8 | DNAH11 | Q96DT5 | 778 |
| SP8 | EMX2 | Q04743 | 731 |
| SP8 | WNT3 | P56703 | 689 |
| SP8 | ACRV1 | P26436 | 662 |
| SP8 | GSX2 | Q9BZM3 | 621 |
| SP8 | DLX2 | Q07687 | 592 |
| SP8 | SHH | Q15465 | 587 |
| SP8 | NR2F1 | P10589 | 584 |
| SP8 | PAX6 | P26367 | 576 |
| SP8 | FGF10 | O15520 | 573 |
| SP8 | BMPR1A | P36894 | 537 |
| SP8 | FGF17 | O60258 | 489 |
| SP8 | LHX2 | P50458 | 487 |
| SP8 | EMX1 | Q04741 | 485 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SDCBP | SP8 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZNF273 | SP8 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF519 | SP8 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HEYL | SP8 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (5): SP8 (Proximity Label-MS), SP8 (Proximity Label-MS), SP8 (Two-hybrid), SP8 (Two-hybrid), SP8 (Two-hybrid)
ESM2 similar proteins: A0JC51, G3V7L5, O57311, O57401, O60481, O73689, O77215, O95409, P07247, P0CG40, P17208, P20264, P20266, P23441, P23769, P28166, P31361, P32027, P39768, P43698, P43699, P46152, P46684, P50220, Q01851, Q04649, Q08369, Q0VGT2, Q12837, Q15915, Q24573, Q5XGT8, Q62520, Q62521, Q63262, Q63934, Q64HY3, Q6DJQ6, Q7TQ40, Q8BMJ8
Diamond homologs: A5ABV9, O08876, O14901, O70494, O89090, O89091, P08047, P0CG40, P41696, Q01714, Q02446, Q02447, Q0VA40, Q13351, Q22678, Q3SY56, Q5XGT8, Q62445, Q64HY3, Q64HY5, Q6BEB4, Q6NW96, Q6P0J3, Q8BMJ8, Q8IXZ3, Q8K1S5, Q8TDD2, Q8VI67, Q90WR8, Q9ESX2, Q9JHX2, Q9TZ64, A1C6L9, A1DH89, A2QCJ9, B0XSK6, B8NGC8, G4N3L5, K9GKQ6, O14335
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 67 |
| Likely benign | 25 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
317 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:20786776:ACC:A | donor_gain | 0.9900 |
| 7:20786777:CCC:C | donor_gain | 0.9900 |
| 7:20786776:AC:A | donor_gain | 0.9800 |
| 7:20786777:CC:C | donor_gain | 0.9800 |
| 7:20786770:AGACT:A | donor_loss | 0.9700 |
| 7:20786771:GACTC:G | donor_loss | 0.9700 |
| 7:20786772:ACT:A | donor_loss | 0.9700 |
| 7:20786773:CT:C | donor_loss | 0.9700 |
| 7:20786774:TCA:T | donor_loss | 0.9700 |
| 7:20786775:C:CA | donor_loss | 0.9700 |
| 7:20786776:A:C | donor_loss | 0.9700 |
| 7:20786777:C:A | donor_loss | 0.9700 |
| 7:20786769:GAGAC:G | donor_loss | 0.9600 |
| 7:20786776:A:AC | donor_gain | 0.9500 |
| 7:20786777:C:CC | donor_gain | 0.9500 |
| 7:20785792:CTTC:C | acceptor_gain | 0.9300 |
| 7:20785793:TTCC:T | acceptor_loss | 0.9100 |
| 7:20785795:CCTG:C | acceptor_loss | 0.9100 |
| 7:20785796:CTGCG:C | acceptor_loss | 0.9100 |
| 7:20785847:G:T | acceptor_gain | 0.9000 |
| 7:20785796:C:CC | acceptor_gain | 0.8900 |
| 7:20786777:CCCCT:C | donor_gain | 0.8500 |
| 7:20785793:TTC:T | acceptor_gain | 0.8300 |
| 7:20785800:G:T | acceptor_gain | 0.8100 |
| 7:20786776:ACCC:A | donor_gain | 0.8100 |
| 7:20786777:CCCC:C | donor_gain | 0.8100 |
| 7:20785799:C:CT | acceptor_gain | 0.7900 |
| 7:20786039:CCACG:C | acceptor_gain | 0.7800 |
| 7:20786040:CACGC:C | acceptor_gain | 0.7800 |
| 7:20786042:CG:C | acceptor_gain | 0.7700 |
AlphaMissense
3253 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:20784461:G:C | H434Q | 1.000 |
| 7:20784461:G:T | H434Q | 1.000 |
| 7:20784462:T:C | H434R | 1.000 |
| 7:20784463:G:C | H434D | 1.000 |
| 7:20784463:G:T | H434N | 1.000 |
| 7:20784471:A:G | L431P | 1.000 |
| 7:20784477:T:A | D429V | 1.000 |
| 7:20784484:G:T | R427S | 1.000 |
| 7:20784488:G:C | F425L | 1.000 |
| 7:20784488:G:T | F425L | 1.000 |
| 7:20784489:A:C | F425C | 1.000 |
| 7:20784489:A:G | F425S | 1.000 |
| 7:20784490:A:G | F425L | 1.000 |
| 7:20784494:C:A | K423N | 1.000 |
| 7:20784494:C:G | K423N | 1.000 |
| 7:20784500:G:C | C421W | 1.000 |
| 7:20784501:C:G | C421S | 1.000 |
| 7:20784501:C:T | C421Y | 1.000 |
| 7:20784502:A:G | C421R | 1.000 |
| 7:20784502:A:T | C421S | 1.000 |
| 7:20784509:A:C | C418W | 1.000 |
| 7:20784510:C:G | C418S | 1.000 |
| 7:20784510:C:T | C418Y | 1.000 |
| 7:20784511:A:G | C418R | 1.000 |
| 7:20784511:A:T | C418S | 1.000 |
| 7:20784515:G:C | F416L | 1.000 |
| 7:20784515:G:T | F416L | 1.000 |
| 7:20784516:A:G | F416S | 1.000 |
| 7:20784517:A:G | F416L | 1.000 |
| 7:20784533:G:C | H410Q | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000251075 (7:20785133 C>G,T), RS1000989047 (7:20783785 G>A,C,T), RS1001058278 (7:20783534 A>C,T), RS1001677623 (7:20782712 C>G,T), RS1001766025 (7:20788793 T>C,G), RS1001817070 (7:20788403 T>C), RS1002049983 (7:20783477 G>A), RS1002150527 (7:20787029 T>A,C,G), RS1003130183 (7:20788324 G>A), RS1003589800 (7:20788778 G>A,T), RS1003719621 (7:20782006 T>A), RS1003769533 (7:20785975 G>A), RS1005603927 (7:20788860 G>T), RS1005793188 (7:20783241 T>C), RS1005957229 (7:20787292 A>G)
Disease associations
OMIM: gene MIM:608306 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000635_9 | Response to statin therapy | 7.000000e-06 |
| GCST000654_2 | Bipolar I disorder | 5.000000e-07 |
| GCST001942_12 | Prostate cancer | 5.000000e-13 |
| GCST005956_25 | Waist-to-hip ratio adjusted for BMI | 3.000000e-08 |
| GCST005962_47 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 7.000000e-07 |
| GCST007328_47 | Alcohol consumption (drinks per week) | 2.000000e-08 |
| GCST008476_4 | Emphysema annual change measurement in smokers (percent low attenuation area) | 1.000000e-06 |
| GCST009798_31 | Asthma | 2.000000e-13 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0007626 | emphysema imaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases methylation, affects cotreatment, decreases expression | 7 |
| trichostatin A | affects cotreatment, decreases expression, increases expression | 4 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tretinoin | affects expression, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| cupric chloride | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression, decreases reaction | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Panobinostat | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation, affects methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Lipopolysaccharides | decreases reaction, increases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A6P4 | SEES3-1V human SP8, clone1 | Embryonic stem cell | Male |
| CVCL_A6P5 | SEES3-1V human SP8, clone2 | Embryonic stem cell | Male |
| CVCL_A6P6 | SEES3-1V human SP8, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.